Original Article

Adenovirus-5 and adenovirus-37 seropositivity in obese patients

Abstract

Background and Objectives: Obesity is a major health issue linked to conditions like diabetes, hypertension, and hyperlipidemia. Infectobesity suggests that certain microorganisms may contribute to obesity. Human adenovirus serotypes, particularly Human adenovirus type-36 (HAdV-36), Human adenovirus type-5 (HAdV-5), and Human adenovirus type-37 (HAdV-37), are thought to influence body fat regulation. This study investigates the relationship between Immunoglobulin G (IgG) positivity for HAdV-5 and HAdV-37 and obesity, aiming to provide data on the infectious etiology of obesity.
Materials and Methods: Blood samples separated into serums from obese (BMI ≥30) and non-obese (BMI 18.5-25) individuals were tested for HAdV-5 and HAdV-37 seropositivity using ELISA kits and seropositivity rates between the groups were compared.
Results: HAdV-37 antibody positivity was significantly higher in obese patients (39/48) compared to the control group (24/42) (p=0.011). For HAdV-5, antibody positivity was similar in both groups (26 individuals each) with no significant difference (p=0.461). No significant gender-related differences were found for either serotype.
Conclusion: The study suggests HAdV-37 may be associated with obesity, while no such relationship was found for HAdV-5. There was no gender association for either serotype. These results align with existing literature on HAdV-37, but further research is needed to confirm the link between adenoviruses and obesity and explore potential treatment options.

1. Shang Q, Wang H, Song Y, Wei L, Lavebratt C, Zhang F, et al. Serological data analyses show that adenovirus 36 infection is associated with obesity: A meta-analysis involving 5739 subjects. Obesity (Silver Spring) 2014; 22: 895-900.
2. Katzmarzyk PT, Chaput JP, Fogelholm M, Hu G, Maher C, Maia J, et al. International study of childhood obesity, lifestyle and the environment (ISCOLE): contributions to understanding the global obesity epidemic. Nutrients 2019; 11: 848.
3. Dhurandhar NV. Infectobesity: obesity of infectious origin. J Nutr 2001; 131: 2794S-2797S.
4. Na H-N, Nam J-H. Infectobesity: a new area for microbiological and virological research. J Bacteriol Virol 2011; 41: 65-76.
5. Ponterio E, Gnessi L. Adenovirus 36 and obesity: An overview. Viruses 2015; 7: 3719-3740.
6. Atkinson RL. Viruses as an etiology of obesity. Mayo Clin Proc 2007; 82: 1192-1198.
7. Paracchını V, Pedotti P, Taioli E. Genetics of leptin and obesity: A HuGE review. Am J Epidemiol 2005; 162: 101-114.
8. López-Ortega O, Moreno-Corona NC, Cruz-Holguin VJ, Garcia-Gonzalez LD, Helguera- Repetto AC, Romero-Valdovinos M, et al. The immune response in adipocytes and Their susceptibility to infection: A possible relationship with infectobesity. Int J Mol Sci 2022; 23: 6154.
9. Cakmakliogullari EK, Sanlidag T, Ersoy B, Akcali S, Var A, Cicek C. Are human adenovirus-5 and 36 associated with obesity in children? J Investig Med 2014; 62: 821-824.
10. Sapunar J, Fonseca L, Molina V, Ortiz E, Barra MI, Reimer C, et al. Adenovirus 36 seropositivity is related to obesity risk, glycemic control, and leptin levels in Chilean subjects. Int J Obes (Lond) 2020; 44: 159-166.
11. Karamese M, Altoparlak U, Turgut A, Aydogdu S, Karamese SA. The relationship between adenovirus-36 seropositivity, obesity and metabolic profile in Turkish children and adults. Epidemiol Infect 2015; 143: 3550-3556.
12. Voss JD, Atkinson RL, Dhurandhar NV. Role of adenoviruses in obesity. Rev Med Virol 2015; 25: 379-387.
13. Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ, et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 2007; 31: 87-96.
14. Whigham LD, Israel BA, Atkinson RL. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 2006; 290: R190-R194.
15. Trovato GM, Martines GF, Pirri C, Trovato FM, Castro A, Garozzo A, et al. Obesity-independent AAssociation of HHuman adenovirus Ad37 seropositivity with onalcoholic fatty liver disease. J Clin Gastroenterol 2012; 46(6): e46-54.
16. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281-286.
17. So PW, Herlihy AH, Bell JD. Adiposity induced by adenovirus 5 inoculation. Int J Obes (Lond) 2005; 29: 603-606.
18. Montes-Galindo DA, Espiritu-Mojarro AC, Melnikov V, Moy-López NA, Soriano-Hernandez AD, Galvan-Salazar HR, et al. Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters. Arch Virol 2019; 164: 775-786.
Files
IssueVol 16 No 5 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v16i5.16804
Keywords
Obesity; Human adenovirus; Serotype; Adipocytes; Infections
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Bostan NG, Altinok O, Buyukasik S, Alis H, Oner Y. Adenovirus-5 and adenovirus-37 seropositivity in obese patients. Iran J Microbiol. 2024;16(5):684-688.